Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
May 14, 2005
Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12
Ritsuko Komaki, R Suzanne Swann, David S Ettinger, et al.
American Journal of Clinical Oncology
|
January 29, 2015
Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non-Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials
Corey J Langer, Mark A Socinski, Jyoti D Patel, et al.
Investigational New Drugs
|
May 9, 2008
Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancer
Daniel G Stover, A Craig Lockhart, Jordan D Berlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2008
A phase I and pharmacokinetic study of the oral histone deacetylase inhibitor, MS-275, in patients with refractory solid tumors and lymphomas
Lia Gore, Mace L Rothenberg, Cindy L O'Bryant, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 1, 2009
A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC)
Anshu K Jain, Randall S Hughes, Alan B Sandler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 2008
Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599
Suresh S Ramalingam, Suzanne E Dahlberg, Corey J Langer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2009
Steps and time to process clinical trials at the Cancer Therapy Evaluation Program
David M Dilts, Alan B Sandler, Steven K Cheng, et al.
Cancer
|
September 19, 2002
Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma
Mark A Socinski, Alan B Sandler, Valerie K Israel, et al.
The Oncologist
|
November 10, 2009
Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy
Luigi Moretti, David S Yu, Heidi Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2009
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer
Robert Mutter, Bo Lu, David P Carbone, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
International Journal of Radiation Oncology, Biology, Physics
|
May 14, 2005
Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12
Ritsuko Komaki, R Suzanne Swann, David S Ettinger, et al.
American Journal of Clinical Oncology
|
January 29, 2015
Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non-Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials
Corey J Langer, Mark A Socinski, Jyoti D Patel, et al.
Investigational New Drugs
|
May 9, 2008
Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancer
Daniel G Stover, A Craig Lockhart, Jordan D Berlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2008
A phase I and pharmacokinetic study of the oral histone deacetylase inhibitor, MS-275, in patients with refractory solid tumors and lymphomas
Lia Gore, Mace L Rothenberg, Cindy L O'Bryant, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 1, 2009
A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC)
Anshu K Jain, Randall S Hughes, Alan B Sandler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 2008
Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599
Suresh S Ramalingam, Suzanne E Dahlberg, Corey J Langer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2009
Steps and time to process clinical trials at the Cancer Therapy Evaluation Program
David M Dilts, Alan B Sandler, Steven K Cheng, et al.
Cancer
|
September 19, 2002
Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma
Mark A Socinski, Alan B Sandler, Valerie K Israel, et al.
The Oncologist
|
November 10, 2009
Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy
Luigi Moretti, David S Yu, Heidi Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2009
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer
Robert Mutter, Bo Lu, David P Carbone, et al.
Page
of 7